Mesut Yılmaz

28PUBLICATIONS
143CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 27, 2026
Erythrocyte Transfusion as an Independent Predictor of Survival but Not Immune-Related Toxicity in Nivolumab-Treated Metastatic NSCLC: A Multicenter Cohort.

|Aug 26, 2026
Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window.

|Aug 26, 2026
Prognostic Value of BMI in Patients with Metastatic Cervical Cancer:A Retrospective Study From Turkey.

|Jun 12, 2026
Association Between ABO Blood Group and Survival in Early-Stage Colon Cancer: A Single-Center Retrospective Cohort Analysis.

|May 27, 2026
Multimodal management of giant prolactinoma with extensive amyloid spherule deposition: a case report with review of the literature.

|May 12, 2026
Prognostic factors and survival outcomes in older adults with extensive-stage small cell lung cancer: A multicenter retrospective cohort study.

Pageof 5

Frequent Collaborators

10 joint publications

Rumeysa Colak

7 joint publications

Nargiz Majıdova

5 joint publications

Caner Kapar

4 joint publications

Özkan Alan